Nanalysis Scientific Corp (NSCI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,376 | 759 | 3,525 | 10,405 | 3,158 |
| Receivables | 11,066 | 9,758 | 8,983 | 6,100 | 3,045 |
| Inventories | 4,386 | 5,794 | 7,387 | 3,679 | 2,830 |
| Other current assets | 1,430 | 1,603 | 2,060 | 0 | 0 |
| TOTAL | $18,258 | $17,914 | $21,955 | $20,762 | $9,352 |
| Non-Current Assets | |||||
| PPE Net | 2,893 | 4,737 | 6,424 | 2,539 | 1,950 |
| Investments And Advances | 0 | 5,727 | N/A | N/A | N/A |
| Intangibles | 18,742 | 21,642 | 39,710 | 14,492 | 12,687 |
| Other Non-Current Assets | 2,478 | 3,804 | 1,813 | 0 | 0 |
| TOTAL | $24,113 | $35,910 | $47,947 | $17,031 | $14,637 |
| Total Assets | $42,371 | $53,824 | $69,902 | $37,793 | $23,989 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,015 | 6,490 | 3,655 | 1,936 | 209 |
| Accounts payable and accrued liabilities | 5,826 | 5,081 | 5,759 | 4,441 | 2,619 |
| Other current liabilities | 299 | 428 | 810 | N/A | N/A |
| TOTAL | $14,377 | $14,596 | $13,506 | $8,646 | $6,303 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,142 | 12,557 | 3,786 | 2,745 | 2,815 |
| Deferred Revenues | 1,193 | 1,321 | 1,932 | 1,798 | 2,868 |
| Other Non-Current Liabilities | 158 | 0 | -11,304 | 319 | 0 |
| TOTAL | $12,448 | $15,747 | $8,824 | $5,186 | $3,342 |
| Total Liabilities | $26,825 | $30,343 | $22,330 | $13,832 | $9,645 |
| Shareholders' Equity | |||||
| Common Shares | 57,565 | 53,201 | 49,016 | 31,295 | 20,665 |
| Retained earnings | -48,602 | -34,989 | -18,793 | -9,692 | -7,920 |
| Other shareholders' equity | 584 | 596 | 1,816 | 714 | 215 |
| TOTAL | $15,546 | $23,481 | $35,130 | $23,961 | $14,344 |
| Total Liabilities And Equity | $42,371 | $53,824 | $57,460 | $37,793 | $23,989 |